BRPI0408978B8 - processos para regenerar uma fase estacionária cromatográfica - Google Patents

processos para regenerar uma fase estacionária cromatográfica

Info

Publication number
BRPI0408978B8
BRPI0408978B8 BRPI0408978A BRPI0408978A BRPI0408978B8 BR PI0408978 B8 BRPI0408978 B8 BR PI0408978B8 BR PI0408978 A BRPI0408978 A BR PI0408978A BR PI0408978 A BRPI0408978 A BR PI0408978A BR PI0408978 B8 BRPI0408978 B8 BR PI0408978B8
Authority
BR
Brazil
Prior art keywords
stationary phase
regenerating
processes
chromatographic stationary
chromatographic
Prior art date
Application number
BRPI0408978A
Other languages
English (en)
Inventor
Schroder Rasmussen Eigil
Schou Ole
Larsen Per
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36118397&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0408978(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority claimed from PCT/DK2004/000234 external-priority patent/WO2004089504A1/en
Publication of BRPI0408978A publication Critical patent/BRPI0408978A/pt
Publication of BRPI0408978B1 publication Critical patent/BRPI0408978B1/pt
Publication of BRPI0408978B8 publication Critical patent/BRPI0408978B8/pt

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/20—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the conditioning of the sorbent material
    • B01D15/203—Equilibration or regeneration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/282—Porous sorbents
    • B01J20/283—Porous sorbents based on silica
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/282—Porous sorbents
    • B01J20/285—Porous sorbents based on polymers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/34—Regenerating or reactivating
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/34—Regenerating or reactivating
    • B01J20/3425—Regenerating or reactivating of sorbents or filter aids comprising organic materials
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/34—Regenerating or reactivating
    • B01J20/345—Regenerating or reactivating using a particular desorbing compound or mixture
    • B01J20/3475—Regenerating or reactivating using a particular desorbing compound or mixture in the liquid phase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/34—Regenerating or reactivating
    • B01J20/3433—Regenerating or reactivating of sorbents or filter aids other than those covered by B01J20/3408 - B01J20/3425

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"processos para regenerar uma fase estacionária cromatográfica e para produzir um polipeptídeo terapêutico ou um precursor do mesmo, uso do mesmo, fase estacionária cromatográfica, produto de polipeptídeo, equipamento cromatográfico automatizado, e, composição farmacêutica". processo para regenerar fases estacionárias cromatográficas.
BRPI0408978A 2003-04-08 2004-04-02 processos para regenerar uma fase estacionária cromatográfica BRPI0408978B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DKPA200300536 2003-04-08
DKPA200300536 2003-04-08
DKPA200400098 2004-01-26
DKPA200400098 2004-01-26
PCT/DK2004/000234 WO2004089504A1 (en) 2003-04-08 2004-04-02 Regeneration of chromatographic stationary phases

Publications (3)

Publication Number Publication Date
BRPI0408978A BRPI0408978A (pt) 2006-04-04
BRPI0408978B1 BRPI0408978B1 (pt) 2018-05-15
BRPI0408978B8 true BRPI0408978B8 (pt) 2021-07-27

Family

ID=36118397

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408978A BRPI0408978B8 (pt) 2003-04-08 2004-04-02 processos para regenerar uma fase estacionária cromatográfica

Country Status (4)

Country Link
US (2) US20060102561A1 (pt)
KR (1) KR101198346B1 (pt)
CN (1) CN1771080B (pt)
BR (1) BRPI0408978B8 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007121271A (ja) * 2005-09-30 2007-05-17 National Institute Of Advanced Industrial & Technology ８−ヒドロキシ−２’−デオキシグアノシンの測定方法及び測定のための装置
WO2010066676A1 (en) * 2008-12-09 2010-06-17 Upfront Chromatography A/S Method of removal of unbound, entrained and/or non-specifically adsorbed material from an affinity chromatography column
CN102460147A (zh) * 2009-06-24 2012-05-16 弗·哈夫曼-拉罗切有限公司 可重复使用的色谱设备的鉴定
HUE034308T2 (en) 2013-03-21 2018-02-28 Sanofi Aventis Deutschland Preparation of hydantoin-containing peptide products
US10450343B2 (en) 2013-03-21 2019-10-22 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
EP3041593B1 (en) 2013-09-05 2025-01-29 F. Hoffmann-La Roche AG Method of cleaning a chromatography material for its reuse
CN105424839A (zh) * 2015-12-15 2016-03-23 袁泳 高效液相色谱仪中反相填料柱的再生方法
CN105964606B (zh) * 2016-04-22 2018-07-10 内蒙古蒙牛乳业（集团）股份有限公司 延长色谱柱使用寿命的清洗方法
CN109011698B (zh) * 2018-08-25 2020-12-01 江苏曼氏生物科技股份有限公司 一种硅胶填料分离柱在线清洗及储存方法
CN112933660A (zh) * 2020-09-11 2021-06-11 石家庄新奥环保科技有限公司 一种离子色谱保护柱再生方法
CN112843789A (zh) * 2020-12-29 2021-05-28 上海赛梵科分离技术有限公司 大麻二酚纯化中色谱填料和层析介质的再生方法
JP2024505100A (ja) * 2021-02-02 2024-02-02 バイオコン バイオロジクス リミテッド シリカベース逆相クロマトグラフィー材料の再生のためのプロセス
JP2024518400A (ja) * 2021-05-07 2024-05-01 ジェンザイム・コーポレーション 衛生化のための組成物および方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164481A (en) * 1978-01-27 1979-08-14 The Dow Chemical Company Process of regenerating a noble metal catalyst used in the reduction of organic nitro compounds
SU1270689A1 (ru) 1984-12-17 1986-11-15 Предприятие П/Я В-8644 Способ регенерации хроматографической колонки
AU598205B2 (en) * 1985-08-22 1990-06-21 Gropep Pty Ltd Peptide analogues of mammalian insulin-like growth factor-1
CA2028848A1 (en) 1989-04-11 1990-10-12 Tapan Audhya Lyophilized peptide formulations
DE4028120C2 (de) * 1990-09-05 1996-09-19 Hoechst Ag Verfahren zur Reinigung von Insulin und/oder Insulinderivaten
US5837826A (en) * 1995-02-27 1998-11-17 Regents Of The University Of Minnesota Protein adsorption by very dense porous zirconium oxide particles in expanded beds
US6852690B1 (en) * 1995-08-22 2005-02-08 Amylin Pharmaceuticals, Inc. Method and composition for enhanced parenteral nutrition
US6115233A (en) 1996-06-28 2000-09-05 Lsi Logic Corporation Integrated circuit device having a capacitor with the dielectric peripheral region being greater than the dielectric central region
UA65549C2 (uk) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
DE19652713C2 (de) * 1996-12-18 2001-11-22 Aventis Pharma Gmbh Verfahren zur Reinigung von Insulin und Insulinderivaten durch Chromatographie an stark saurem Kationenaustauscher
JPH10221323A (ja) * 1997-02-10 1998-08-21 Teijin Ltd 吸着カラムの連続使用方法及び装置
JP2002501427A (ja) * 1997-03-31 2002-01-15 バテル・メモリアル・インスティテュート 廃棄流体からアンモニアを除去する装置及び方法
AU2712899A (en) 1998-02-27 1999-09-15 Novo Nordisk A/S Glp-2 derivatives with helix-content exceeding 25 percent, forming partially structured micellar-like aggregates
DE69916811T2 (de) 1998-02-27 2005-04-14 Novo Nordisk A/S Glp-1 derivate mit einem helix-gehalt über 25 %, die partiell strukturierte mizellenartige aggregate bilden
CA2358107C (en) 1998-12-22 2011-08-23 Eli Lilly And Company Shelf-stable formulation of glucagon-like peptide-1
RU2242244C2 (ru) 1999-01-14 2004-12-20 Амилин Фармасьютикалз, Инк. Новые композиции агонистов эксендина и способы их введения
US6248683B1 (en) * 1999-04-07 2001-06-19 Silicycle Inc. Process for the regeneration of used silica gel
PT1180121E (pt) * 1999-05-17 2004-03-31 Conjuchem Inc Peptidos insulinotropicos de longa duracao
NZ517632A (en) 1999-08-09 2004-02-27 Pharmacia & Upjohn Spa Formulations for parenteral use of estramustine phosphate and albumin
JP2001133446A (ja) 1999-08-20 2001-05-18 Sekisui Chem Co Ltd 液体クロマトグラフ装置及びこれに用いる洗浄液
ES2240187T3 (es) 1999-10-08 2005-10-16 V.I. Technologies, Inc. Composiciones sanguineas desprovistas de isoaglutinina y metodos para fabricarlas.
JP4473999B2 (ja) 2000-01-17 2010-06-02 積水化学工業株式会社 カラム洗浄液
US6550320B1 (en) * 2000-05-31 2003-04-22 Continental Ag System and method for predicting tire forces using tire deformation sensors
EP2226385B1 (en) 2000-09-13 2013-07-10 Novo Nordisk Health Care AG Human Coagulation Factor VII Variants
SI1724284T1 (sl) 2000-12-07 2009-12-31 Lilly Co Eli Glp-1 fuzijski proteini
JPWO2002068116A1 (ja) * 2001-02-28 2004-06-24 出光興産株式会社 吸着剤の再生方法
JP2002265383A (ja) 2001-03-14 2002-09-18 Mitsubishi Pharma Corp インターフェロンα注射用液状製剤
FI20010977A7 (fi) * 2001-05-09 2002-11-10 Danisco Sweeteners Oy Kromatografinen erotusmenetelmä
ES2298378T3 (es) 2001-06-28 2008-05-16 Novo Nordisk A/S Formulacion estable de glp-1 modificado.
CN1639166A (zh) * 2002-02-28 2005-07-13 马林克罗特公司 通过反相制备色谱法分离和纯化至少一种麻醉生物碱的方法和系统
AU2003239478A1 (en) 2002-06-04 2003-12-22 Eli Lilly And Company Modified glucagon-like peptide-1 analogs
SI1545574T1 (sl) * 2002-09-13 2014-10-30 Biogen Idec Inc. Postopek za čiščenje polipeptidov s simulirano "moving bed" kromatografijo
DE10347975B4 (de) 2002-10-24 2008-10-09 Siemens Ag Einrichtung der programmierbaren Logik
RU2239827C1 (ru) 2003-05-12 2004-11-10 Государственный научно-исследовательский институт органической химии и технологии Восстановление аналитических и препаративных колонок для высокоэффективной жидкостной хроматографии (вэжх)
EP1506809A1 (en) * 2003-08-11 2005-02-16 Boehringer Ingelheim Pharma GmbH & Co. KG Regeneration of hydrolysis sensitive adsorbent matrices
US7449116B2 (en) * 2004-10-01 2008-11-11 Agilent Technologies, Inc. Methods and systems for protein separation

Also Published As

Publication number Publication date
BRPI0408978B1 (pt) 2018-05-15
BRPI0408978A (pt) 2006-04-04
US20080312131A1 (en) 2008-12-18
US20060102561A1 (en) 2006-05-18
US9364772B2 (en) 2016-06-14
KR101198346B1 (ko) 2012-11-06
CN1771080A (zh) 2006-05-10
CN1771080B (zh) 2010-12-15
KR20060015496A (ko) 2006-02-17

Similar Documents

Publication Publication Date Title
BRPI0408978A (pt) processos para regenerar uma fase estacionária cromatográfica e para produzir um polipeptìdeo terapêutico ou um precursor do mesmo, uso do mesmo, fase estacionária cromatográfica, produto de polipeptìdeo, equipamento cromatográfico automatizado, e, composição farmacêutica
CL2004001267A1 (es) Compuestos derivados de quinazolina, inhibidor de quinasa; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y su uso para preparar un medicamento para tratar trastornos proliferativos celulares tales como ateroesclerosis,
IL165696A0 (en) Substituted 1,3-diphenykprop-2-en-1-one derivatives and preparation and uses thereof
DE60131881D1 (de) Topische zusammensetzung enthaltend mindestens ein vitamin d oder vitamin d analogon und mindestens ein corticosteroid
MXPA05010682A (es) Compuestos novedosos.
MXPA03008419A (es) Amidas de acido antranilico, metodo para su produccion, su uso como agentes anti-arritmia, y preparaciones farmaceuticas de las mismas.
HUP0303317A3 (en) Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds
ID26207A (id) ESTRATRIENA TERSUBSTITUSI 11β-HALOGEN-7 αTERSUBSTITUTASI, PROSES UNTUK MEMPRODUKSI SEDIAAN FARMASI YANG MENGANDUNG ESTRATRIENA 11β-HALOGEN-7 αINI DAN JUGA PENGGUNAANNYA UNTUK PRODUKSI ZAT-ZAT FARMASI
BR9401959A (pt) Processo para a fabricação de uma mousse de carboneto de silício,processo para a fabricação de um catalisador, carboneto de silício bem como sua aplicação
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
ATE470548T1 (de) Systeme und verfahren zum herstellen von verbundbahnen mit strukturierten, diskreten polymerbereichen
DE602004031301D1 (de) Nichtsymmetrisches geliermittel
TW200612892A (en) Novel compounds
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
ATE367152T1 (de) Herstellungsverfahren für niedrig dosierte pharmazeutische zusammensetzung
ATE552274T1 (de) Mhc-oligomer und verfahren zu dessen herstellung
FR2848428B1 (fr) Composition cosmetique et procede pour le traitement des matieres keratiniques, comprenant un compose photodimerisable
WO2004055513A3 (en) Use of cd137 antagonists for the treatment of tumors
MXPA03007635A (es) P-tienilbencilamidas que sirven como agonistas de receptores para angiotensina-(1-7), metodo para su produccion, su uso y preparaciones farmaceuticas que las contienen.
BRPI9914571B1 (pt) composto, processo para sua preparação, uso do mesmo, bem como composição farmacêutica.
WO2005012271A3 (en) Process for the synthesis of biaryl oxazolidinones
BG102707A (bg) Нови триазолопурини, метод за тяхното получаване и тяхното приложение като лекарствени средства
ES2184300T3 (es) Derivados de aminoacidos utiles para tratar el accidente vascular encefalico.
MXPA05010684A (es) Regeneracion de fases estacionarias cromatograficas.
BR9903274A (pt) Processo para isolar vitamina d3

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) DA LPI

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/04/2004, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI NO 52402.012649/2021-87 ORIGEM: 22A VARA FEDERAL CIVEL DA SJDF (TRF1) PROCESSO NO: 1087272-97.2021.4.01.3400 ACAO DE PROCEDIMENTO COMUM AUTOR: NOVO NORDISK A/S E NOVO NORDISK FARMACEUTICA DO BRASIL LTDA. REU(S): INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL ? INPI

B19A Notification of judicial decision: notification of judicial decision

Free format text: PROCESSO INPI NO 52402.012649/2021-87 SECAO JUDICIARIA DO DISTRITO FEDERAL 22A VARA FEDERAL CIVEL DA SJDF PROCESSO: 1087272-97.2021.4.01.3400 PROCEDIMENTO COMUM CIVEL POLO ATIVO: NOVO NORDISK FARMACEUTICA DO BRASIL LTDA E NOVO NORDISK A/S POLO PASSIVO:INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL ? INPI SENTENCA: HOMOLOGADA A RENUNCIA A PRETENSAO DE ALTERAR O PRAZO DE VIGENCIA DA PATENTE EM RAZAO DA ALEGADA DEMORA DO INPI NA ANALISE DO PROCESSO ADMINISTRATIVO. TRANSITADO EM JULGADO.